The VERVE Symposium in conjunction with LINC Australia program will incorporate a world renowned international faculty, with live cases from the University Hospital in Leipzig, Prince of Wales Private Hospital Sydney and the Mater Hospital Sydney. We are introducing a call for abstracts in the categories of original scientific research and challenging cases with a chance for individuals to join the faculty for a podium or e-poster presentation, providing endovascular techniques, peripheral, carotid, aortic and late breaking trial data and the opportunity for individuals to present their research.
*Program subject to change
To view the session content, please click on the arrow to the right of the session.
7:00 - 7:00 am
Venue – Parkside Ballroom Level 2
8:30 - 10:00 am
Chairs : R. Varcoe, P. Schneider
Panel : M. Brodmann, G. Ansel, J. Van den Berg, I. Meredith
8:30 - 8:35 am
Introductory Remarks
Ramon Varcoe
8:35 - 8:50 am
Live Case from Leipzig (case 1)
8:50 - 8:58 am
Drug Eluting Technology: What Was the Impact of the JAHA Meta-Analysis 1-Year Later
Marianne Brodmann
8:58 - 9:06 am
Paclitaxel Insights from the TOTAL IN.PACT Program
Peter Schneider
9:06 - 9:14 am
Is Drug Based Technology Appropriate for Claudicants, CLI and Dialysis Access?
Gary Ansel
9:14 - 9:22 am
Insights from Coronary Paclitaxel DES Era – Setting the Record Straight 20 Years On
Ian Meredith
9:22 - 9:32 am
Live Case from Leipzig (case 1)
9:32 - 9:40 am
Alternative Explanations for the Safety Signal: The Impact of Clinical Trial Design
Ramon Varcoe
9:40 - 10:00 am
Discussion
10:30 - 12:00 pm
Chair : R. Varcoe
Panel : M. Brodmann, D. Holdaway, K. Rosenfield, A. Ling, I. Spark
Supported by : Abbott Vascular
10:30 - 10:38 am
What is the Role of Open Vascular Surgery in PAD disease in 2020: An Overview of Proposed Indications
Marianne Brodmann
10:38 - 10:46 am
Supera Interwoven Nitinol stent for the Treatment of Femoral and Popliteal arterial Disease
Damien Holdaway
10:46 - 11:14 am
Live Case from POW Sydney (case 3)
11:14 - 11:22 am
Is DCB angioplasty enough in long CTOs?
Ian Spark
11:22 - 11:30 am
Experiences with the Supera Interwoven Nitinol Stent for the Treatment of Severely Calcified Lesions and the Popliteal Artery
Adrian Ling
11:30 - 11:38 am
An Update of the BEST-CLI Trial of Endo vs Open Surgery for Symptomatic PAD
Kenneth Rosenfield
11:38 - 12:00 pm
Discussion
12:00 - 1:00 pm
Room 2
Title : ESKD Symposium: Advances of Endovascular Therapy in AV Access
Discussions around new data, guidelines and interventional technology into treatment paradigms for end-stage kidney disease patients
Supported by : BD Bard
Facilitator : Albert Goh
New KDOQI guidelines
Albert Goh
Latest Data on the Covera™ AVeNEW Trial
Philip Puckridge
Use of Lutonix™ 035 Drug Coated Balloon for challenging AV Access Stenosis
Sven Brunlich
1:00 - 2:40 pm
Chair : S. Bräunlich
Panel : J. Van den Berg, Y. Gouëffic, D. Schneider, P. Mwipitayi
Supported by : Gore
1:00 - 1:20 pm
Live Case from Sydney NSPH (case 4)
1:20 - 1:28 pm
New Technical Developments in Stenting of the Abdominal Aorta and Common Iliac Arteries for Steno-Occlusive Disease
Jos Van den Berg
1:28 - 1:36 pm
A Prospective Registry for the Treatment of Iliac Oclusions with Bare Metal Stent: 2-Year Outcomes
Yann Gouëffic
1:36 - 1:56 pm
Live Case from Auckland (case 5)
1:56 - 2:04 pm
Endografts for Complex Aortoiliac Occlusions
Darren Schneider
2:04 - 2:12 pm
Aortoiliac Occlusive Disease: What Factors Impact Long-Term Outcome after Endovascular Intervention?
Patrice Mwipitayi
2:12 - 2:20 pm
An Update of the VBX Program in Aortoiliac Occlusive Disease
Andrew Holden (via satellite)
2:20 - 2:40 pm
Discussion
2:40 - 4:00 pm
Chair : B. DeRubertis
Panel : J. Golledge, A. Bullen, D. Robinson, P. Puckridge
Supported by : Medtronic
2:40 - 2:48 pm
Directional Atherectomy for the SFA and Popliteal Arteries
Domenic Robinson
2:48 - 3:08 pm
Live Case from Sydney NSPH (case 6)
3:08 - 3:16 pm
Atherectomy: How to Choose the Best Option, Avoid Problems and Bail Yourself Out
Andrew Bullen
3:16 - 3:24 pm
The Role of Non-Drug Eluting Technologies for Fem-Pop Revascularization in Light of the Paclitaxal Data
Phil Puckridge
3:24 - 3:30 pm
Live Case from Sydney NSPH (case 6 continued)
3:30 - 3:38 pm
The Evidence for Hyperbaric Oxygen Therapy in Patients with Diabetes-Related Foot Ulcers
Jonathan Golledge
3:38 - 3:46 pm
Versatility in Vessel Preparation – Directional Atherectomy
Brian DeRubertis
3:46 - 3:54 pm
An Australian Experience Using Combination Therapy Below the Knee
Vik Puttaswamy (via satellite)
3:54 - 4:00 pm
Discussion
4:15 - 6:00 pm
Chairs : H. Verhagen, E. Verhoeven
Panel : T. Kolbel, F. Criado, R. Tripathi, E. Ducasse
Supported by : Gore
4:15 - 4:23 pm
The New C-Tag with Active Controlled Deployment is a Game Changer for TEVAR and Well Suited to the Aortic Arch
Hence Verhagen
4:23 - 4:31 pm
Recorded Case: Aortic Arch and Descending TEVAR
Hence Verhagen
4:31 - 4:51 pm
Live Case from Auckland (case 8)
4:51 - 4:59 pm
Treating Concomitant Disease of the Arch and Thoracic Aorta
Eric Verhoeven
4:59 - 5:07 pm
Key Strategies to Prevent Retrograde Type A Dissection During TEVAR
Frank Criado
5:07 - 5:15 pm
Live Case from Auckland (case 8)
5:15 - 5:23 pm
Endovascular Repair of the Ascending and Aortic Arch
Tilo Kolbel
5:23 - 5:31 pm
Coronary Artery Bypass Grafting (CABG) combined with concomitant endovascular Hybrid repair of Aortic Arch Aneurysms.
Ramesh Tripathi
5:31 - 5:39 pm
CTAG with Active Control: Conformable, Controlled, Predictable
Eric Ducasse
5:39 - 6:00 pm
Discussion
6:00 - 7:30 pm
Venue: Parkside Ballroom Level 2
8:30 - 10:00 am
Chairs : H. Verhagen, F. Criado
Panel : M. Schermerhorn, P. Holt, R. Milner, E. Verhoeven, E. Ducasse
8:30 - 8:35 am
Introductory Remarks
Hence Verhangen
8:35 - 8:43 am
These are the Current Unmet Needs in AAA Treatment
Frank Criado
8:43 - 9:03 am
Live Case from Sydney NSPH (case 2)
9:03 - 9:11 am
EVAR is Associated with Increased Risk in Patients with Increased Luminal Space (Not Sac Diameter)
Hence Verhagen
9:11 - 9:19 am
Treatment Options for Type II Endoleak
Marc Schermerhorn
9:19 - 9:27 am
Outcomes after Endovascular Aneurysm Sealing (EVAS) in 298 Patients
Peter Holt
9:27 - 9:35 am
Live Case from Sydney NSPH (case 2)
9:35 - 9:43 am
Right axillary access is effective and safe for Complex EVAR, ChEVAR and FEVAR
Ross Milner
9:43 - 9:51 am
CO² Imaging Use in PAD and EVAR Treatment. It Really Works!
Eric Ducasse
9:51 - 10:00 am
Discussion
10:30 - 12:00 pm
Chair : K Weaver
10:30 - 10:40 am
Doppler Angle Correction in Vascular Sonography
Teal Derboghossian
10:40 - 10:50 am
Cystic Adventitial Disease
Nathan Gallagher
10:50 - 11:00 am
Duplex Findings in Unusual Venous Pathology
Ian Catchpole
11:00 - 11:10 am
New Ultrasound Technologies: V-Flow
Tricia Mares
11:10 - 11:20 am
IVUS Guided Viabahn Stentgraft Implantation for the Most Complex Femoropopliteal Lesions
Osamu Iida
11:20 - 11:30 am
Takayasu’s in a Young Female Patient: Case study
Daniel Cai
11:30 - 11:40 am
Mega Fistula – Complication of Dialysis Fistulas
Adam Tolfree
11:40 - 11:50 am
Asymptomatic Carotid Artery Screening: Con or Common Sense?
Matt Adams
11:50 - 12:00 pm
Scanning Protocol of an Athlete with Claudication: Case Study of Endofibrosis
Jiawei (Andy) Yang
12:00 - 1:00 pm
Title : ESKD Symposium: Advances of Endovascular Therapy in AV Access
Discussions around new data, guidelines and interventional technology into treatment paradigms for end-stage kidney disease patients
Supported by : BD Bard
Facilitator : Albert Goh
New KDOQI guidelines
Albert Goh
Latest Data on the Covera™ AVeNEW Trial
Philip Puckridge
Use of Lutonix™ 035 Drug Coated Balloon for challenging AV Access Stenosis
Sven Brunlich
1:00 - 2:40 pm
Chairs : L. Villalba, P. Mwipitayi
Panel : R. Tripathi, M. Razavi, T. Nguyen, L. Leon
Supported by : Philips
1:00 - 1:10 pm
The Use of IVUS in the Diagnosis and Treatment of Major Vein Disorders: An Indispensable tool
Patrice Mwipitayi
1:10 - 1:20 pm
Endovascular Management of Inferior Vena Cava: Acute and Chronic Obstruction
Luis Leon
1:20 - 1:30 pm
Failure modes of Iliac veins stents and what we can do about them
Ramesh Tripathi
1:30 - 1:40 pm
Deep Venous In-Stent Restenosis: Pathological Evidence as to its Cellular Origins
Cameron Robertson
1:40 - 1:50 pm
Treatment of Venous Thoracic Outlet Syndrome Using Angiojet, Rib Resection and Vein Patch Reconstruction
Tam Nguyen
1:50 - 2:00 pm
Strategies for Managing Central Venous Occlusions
Mahmood Razavi
2:00 - 2:10 pm
Crossover catheter-directed thrombolysis for Acute DVT involving the whole leg
Mingjin Guo
2:10 - 2:20 pm
Latest Results from the INFINITE-OUS BlueLeaf Endovenous Valve Formation System
Thodur Vasudevan
2:20 - 2:30 pm
Real Patient Stories of Surviving DVT and PE
Laurencia Villalba
2:30 - 2:40 pm
Discussion
2:40 - 4:00 pm
Chair : R. Milner
Panel : E. Verhoeven, M. Sebastian, E. Ducasse, D. Schneider
2:40 - 2:48 pm
Experience with the Gore Excluder graft in More than 300 cases: Does Off IFU Matter?
Eric Verhoeven
2:48 - 3:08 pm
Live Case from POW Sydney (case 7)
3:08 - 3:16 pm
How the Endurant Graft Improves My Ability to Treat More Challenging Aortic Necks with Good Long-Term Outcomes
Ross Milner
3:16 - 3:24 pm
The Use of EVAR for the Treatment of Mycotic Aneurysms
Mathew Sebastian
3:24 - 3:32 pm
Tips and Tricks for a Perfect Physician Modified Fenestrated Endograft when Required
Eric Ducasse
3:32 - 3:47 pm
Live Case from POW Sydney (case 7)
3:47 - 3:55 pm
FEVAR and BEVAR for the Management of Failed EVAR
Darren Schneider
3:55 - 4:03 pm
EVAR in Complex Anatomy, Lessons Learned from ENGAGE and GREAT Registries
Patrice Mwipitayi
Discussion
4:15 - 6:00 pm
Chairs : P. Schneider, S. Braunlich
Panel : J. Mustapha, T. Nakama, J. Golledge, M. Brodmann
4:15 - 4:23 pm
Rutherford 6 wounds-the utility of multi-vessel revascularization and inflow strategies
Peter Schneider
4:23 - 4:31 pm
The Technique of Distal Puncture for BTK Occlusion
Tatsuya Nakama
4:31 - 4:51 pm
Live Case from Leipzig (case 9)
4:51 - 4:59 pm
Using Rotarex in BTK Arteries: Where Can it be Used Most Safely and Effectively
Sven Bräunlich
4:59 - 5:07 pm
Does the Downstream Effect After Drug-Coated Balloon Treatment Impact Time to Wound Healing in CLI?
Osamu Iida
5:07 - 5:22 pm
Live Case from Leipzig (case 10)
5:22 - 5:30 pm
How Best to Define and Treat “No Option” CLI Patients
Marianne Brodmann
5:30 - 5:38 pm
Venous Arterialization for Patients with Recurrent TLR Facing Possible Amputation: Results from a Single Center Observational Study
Jihad Mustapha
5:38 - 5:46 pm
The Unrealized Potential of Effective Medical Management in People with Peripheral Artery Disease
Jonathan Golledge
5:46 - 6:00 pm
Discussion
6:00 - 7:30 pm
Venue: Parkside Ballroom Level 2
7:00 - 7:00 am
Venue – Parkside Ballroom Level 2
8:00 - 9:30 am
Chair: G. Ansel
Panel : Y. Goueffic, L. Villalba, N. Altaf
Supported by : Boston Scientific
8:00 - 8:08 am
SAVAL BTK Trial Update: Unique Stent Technology for Complex Tibial Anatomy
Sven Braunlich
8:08 - 8:28 am
Live Case from Leipzig (Case 11)
8:28 - 8:36 am
An Australian Health Economic Evaluation for the Eluvia drug-eluting stent
Nishath Altaf
8:36 - 8:44 am
Final Results of the Ranger II Pivotal Trial
Marianne Brodman
8:44 - 9:02 am
Live Case from Leipzig (case 11)
9:02 - 9:10 am
Jetstream Atherectomy for the Treatment of In-stent Restenosis of the Femoropopliteal Artery: Preliminary Results of the JET-ISR Study
Patrice Mwipitayi
9:10 - 9:18 am
ELUVI – An Update
Andrew Holden
9:18 - 9:30 am
Discussion
9:30 - 11:00 am
Chair : Sven Braunlich
Panel : S. Bräunlich, J. Van den Berg, S. Thomas, L. Leon
Supported by : BD Bard
9:30 - 9:38 am
An Update on the Lutonix PAD Global Registry
Sven Bräunlich
9:38 - 10:00 am
Live Case from MAT Sydney (Case 13)
10:00 - 10:08 am
Safety and Efficacy of the Phoenix Atherectomy System in the Treatment of Multilevel Infrainguinal Arterial Disease
Luis Leon
10:08 - 10:16 am
Innovative Solutions to Complex Re-Do CLI Procedures
Shannon Thomas
10:16 - 10:24 am
The Lutonix BTK Trial 1-Year Update: Which Direction Should These Results Take Us?
Sven Braunlich
10:24 - 10:34 am
Live Case from MAT Sydney (case 13)
10:34 - 10:42 am
The Treatment of Embolic Complications in Peripheral Vascular Interventions
Jos Van den Berg
10:42 - 11:00 am
Discussion
11:30 - 1:00 pm
Chairs : R. Milner, F. Criado
Panel : M. Schermerhorn, R. Qasabian, T. Kolbel, E. Verhoeven
Supported by : Medtronic
11:30 - 11:38 am
Update from the Valiant Navion clinical trial: A New Generation of TEVAR device
Ross Milner
11:38 - 11:53 am
Recorded Case from Auckland (case 14)
11:53 - 12:01 pm
Chronic Dissection and False Lumen Occlusion Techniques
Tilo Kolbel
12:01 - 12:09 pm
Setting up a Thoracoabdominal Program in an Australian Teaching Hospital
Raffi Qasabian
12:09 - 12:16 pm
3D Printing and Customized Pre-fenestration and Branched Stent Graft for the Treatment for Thoracoabdominal Aortic Diseases
Liu Zhao
12:16 - 12:24 pm
What is the Stroke Risk from Complex EVAR and TEVAR: Real World Data from the VQI
Marc Schermerhorn
12:24 - 12:32 pm
An Update of the Treatment of Chronic Dissections
Eric Verhoeven
12:32 - 12:39 pm
Treated covered stent:a reasonable choice for TEVAR of acute aortic dissection
Jian Zhang
12:39 - 12:47 pm
How to Manage the “Fragile” Thoracic Aorta
Phil Puckridge
12:47 - 12:55 pm
Update on Thoracic IMH: Further insights on its nature and indications for intervention
Frank Criado.
12:55 - 1:00 pm
Discussion
1:00 - 2:00 pm
Room 2
Title : New horizons in endovascular care for challenging aortic anatomies. Today and tomorrow.
Supported by : Gore
Facilitator : Hence Verhagen
New approaches to the treatment of challenging aortic anatomies
Hence Verhagen
New horizons in endovascular care: An innovative thoracoabdominal branched device
Darren Schneider
Advanced thoracic innovations for improved physician experience and clinical outcomes
Eric Ducasse
2:00 - 3:30 pm
Chairs : R. De Graaf, M. Razavi
Panel : R. Tripathi, P. Puckridge, P. Mwipitayi
Supported by : BD Bard
2:00 - 2:20 pm
The Technique of Venous Stenting: What We’ve Learned About the Most Challenging Aspects of this Emerging Field
Rick De Graaf
2:20 - 2:28 pm
Have Venous Stent Trials Revealed Any New Data?
Mahmood Razavi
2:28 - 2:53 pm
Live Case from MAT Sydney (Case 15)
2:53 - 3:01 pm
Results from an Australian Venous Stenting Program
Phil Puckridge
3:01 - 3:09 pm
Endophlebectomy And Iliac Vein Stent Placement – How I Do It (Video Technique Demonstration)
Ramesh Tripathi
3:09 - 3:17 pm
Latest Update from the VERNACULAR Trial
Steven Dubenec (via satellite)
3:17 - 3:30 pm
Discussion
4:00 - 6:00 pm
Chair : H. Verhagen
Panel : P. Holt, M. Schermerhorn, E. Verhoeven, I. Mohan
4:00 - 4:15 pm
What’s the Role of Open AAA Surgery in 2020 and Beyond?
Hence Verhagen
4:15 - 4:30 pm
Does Operator and Hospital Volume Make a Difference to Outcomes after Elective and Emergency Aortic Surgery? Results from the Australasian Vascular Audit
Ramon Varcoe
4:30 - 4:40 pm
Complete Replacement of Open Repair for Ruptured Abdominal Aortic Aneurysms by Emergent Endovascular Repair: A 7-Year Experience from A Vascular Centre in Mainland China
Jianing Yue
4:40 - 4:50 pm
An International Comparison of AAA Treatment Rates Across Nine Countries
Peter Holt
4:50 - 5:00 pm
EVAR vs Open Surgical Repair: How Do we Choose the Right Option for Any Given Patient
Marc Schermerhorn
5:00 - 5:10 pm
Centralisation versus Proctoring for Fenestrated and Branched Aortic Stent Grafting: Which Provides Better Outcomes?
Eric Verhoeven
5:10 - 5:20 pm
Endovascular management of ruptured thoracic aortic aneurysm: An Australasian experience
Ian Barry
5:20 - 5:30 pm
DEBATE: Centralization of Elective AAA Results in Safer Surgery with Lower Perioperative Risk
FOR the motion: Peter Holt
5:30 - 5:40 pm
DEBATE: Centralization of Elective AAA Results in Safer Surgery with Lower Perioperative Risk
AGAINST the motion: Irwin Mohan
5:40 - 6:00 pm
Discussion
7:00 - 11:00 pm
Venue: Sergeants Mess, Chowder Bay
6.45 pm – Transfers: Convention Centre Wharf outside Sofitel Sydney Hotel
Coach transfers back to Sofitel Sydney
8:00 - 9:30 am
Chairs : R. Milner, R. Varcoe
Panel : V. Bhamidi, E. Ducasse, E. Verhoeven, D. Schneider
8:00 - 8:08 am
Computational Analysis of Seal Zone Preservation and Migration Resistance with EndoAnchors
Ross Milner
8:08 - 8:28 am
Live Case from Sydney POW (case 12)
8:28 - 8:35 am
Heli-FX: Mid-term results from the ANCHOR Registry: How EndoAnchors Expand EVAR Patient Applicability
Venu Bhamidi
8:35 - 8:43 am
Complications Whilst Waiting for F/BEVAR Stent-Grafts: The Results Might Surprise You
Eric Verhoeven
8:43 - 8:51 am
The IBE: With a Dedicated IIA Component Which Shows Excellent Patency Data
Eric Ducasse
8:51 - 8:59 am
Techniques to Extend the Applicability of lliac Branch Devices
Darren Schneider
8:59 - 9:07 am
Complications and Management Following EVAR during Midterm Follow-up: a Single Center Experience
Jichun Zhao
9:07 - 9:15 am
Dealing with the pending vascular surgery shortage in a multi-institutional vascular institute
Gary Ansel
9:15 - 9:30 am
Discussion
9:30 - 11:00 am
Chairs : J. Robinson, K Weaver
9:30 - 9:40 am
Recommendations & Reality of Infection Protection in the vascular imaging department
John Shirley
9:40 - 9:50 am
Experience with Ultrasound Guided Tibial Angioplasty
Sven Brunlich
9:50 - 10:00 am
No Source Identified?! Venous Malformation in the Form of an intraosseous Perforator
Peter Sharman
10:00 - 10:10 am
llio-Femoral Obstructions: Can We Improve Detection Rates?
Dan Rae
10:10 - 10:20 am
Duplex Findings in Unusual Venous Pathology
Ian Catchpole
10:20 - 10:30 am
What the! – Unusual Arterial Pathologies
Warren Lewis
10:30 - 10:40 am
Pedal Acceleration Time (PAT): A Novel Technique to Evaluate Perfusion in the foot
Jill Sommmerset/Desarom Teso
10:40 - 10:50 am
Live scan: Technique and Application of PAT
Jill Sommmerset/Desarom Teso
10:50 - 11:00 am
How to Set‐up and Perform Contrast‐Enhanced Ultrasound
Gerry Hill
11:30 - 1:00 pm
Chairs : G. Ansel, P. Schneider
Panel : M. Brodmann, A. Holden, K. Rosenfield, O. Iida
11:30 - 11:45 am
A Summary of the VIVA Vascular Leaders Forum
Gary Ansel
11:45 - 11:53 am
Paclitaxel-Is it safe and how should we use it in PAD patients?
Peter Schneider
11:53 - 12:01 pm
Long-Term Results from the IN.PACT Japan Trial
Osamu Iida
12:01 - 12:09 pm
Safety Results from the Lutinox Paclitaxel Coated Balloon Studies
Marianne Brodmann
12:09 - 12:17 pm
ELUVIA – An Update
Andrew Holden
12:17 - 12:25 pm
Long Term Safety and Efficacy of IN.PACT Admiral: (IN.PACT 5 year data)
Brian DeRubertis
12:25 - 12:33 pm
Outcome From a DCB Series versus Historical Control: Recurrence and Mortality
Kishore Sieunarine
12:33 - 12:41 pm
The Impact of Dose on the Paclitaxel Issue
Andrew Holden
12:41 - 12:49 pm
A Coalition of Seven Vascular Societies: Joint Position Statement on Paclitaxel Coated Devices
Kenneth Rosenfield
12:49 - 12:57 pm
Are There Alternatives to Paclitaxel? Different Immunosuppressive Drugs to Prevent Restenosis
Marianne Brodmann
12:57 - 1:00 pm
Discussion
1:00 - 2:00 pm
Title : New horizons in endovascular care for challenging aortic anatomies. Today and tomorrow.
Supported by : Gore
Facilitator : Hence Verhagen
New approaches to the treatment of challenging aortic anatomies
Hence Verhagen
New horizons in endovascular care: An innovative thoracoabdominal branched device
Darren Schneider
Advanced thoracic innovations for improved physician experience and clinical outcomes
Eric Ducasse
2:00 - 3:30 pm
Chair : J. Swinnen
Panel : I. Nammuni, A. Holden, M. Razavi
2:00 - 2:08 pm
Optimising Dialysis Outcomes in the Next Decade: Challenges & Potential Solutions
John Swinnen
2:08 - 2:28 pm
Latest Data From the LUTONIX DCB in AVF Trial
Gerard Goh
2:28 - 2:46 pm
Live Case from Sydney POW (case 16)
2:46 - 2:54 pm
Update of the In.Pact AV Access RCT – Primary Endpoint and Sub-group Analysis
Andrew Holden
2:54 - 3:00 pm
A Superior Approach to Dialysis Fistulography? The Benefits of Using Internal Jugular Access to Perform Diagnostic Angiograms and Interventions
Wasim Hakim
3:00 - 3:08 pm
Mortality After DCB Use in the Failing AVF: A Meta-Analysis of RCTs
Krystal Dinh
3:08 - 3:14 pm
Mortality and Patency of Fistulas treated with Drug-Coated Balloons A Single Centre Retrospective Review
Christina Popovic
3:14 - 3:20 pm
The novel endovascular plication of a thigh arteriovenous fistula using an EVAR limb to treat high-output cardiac failure
Thomas Cavaye
3:20 - 3:28 pm
Forced Maturation of the Arteriovenous Fistula Using Nitinol Stents
Shannon Thomas (via satellite)
3:28 - 3:30 pm
Discussion
4:00 - 6:00 pm
Chairs : A. Holden, G. Ansel
Panel : P. Schneider, T. Nakama, M. Razavi, M. Brodmann
4:00 - 4:08 pm
New Devices and Innovations for Managing CLI
Peter Schneider
4:08 - 4:33 pm
Live Case from Leipzig (case 17)
4:33 - 4:41 pm
Summarising the TOBA Evidence from the Above and Below Knee Clinical Trial Data
Marianne Brodmann
4:41 - 4:49 pm
Intravascular lithoplasty: Study Status (DISRUPT PAD II and III) and Lessons Learnt from a Real-World Registry
Andrew Holden
4:49 - 4:57 pm
The Various Approaches to Femoro-Popliteal CTOs: From $ to $$$
Gary Ansel
4:57 - 5:20 pm
Live Case from Leipzig (case 18)
5:20 - 5:28 pm
What Does it Mean “No option CLI”? : The Possibility of Percutaneous Deep Venous Arterialization
Tatsuya Nakama
5:28 - 5:36 pm
The Role of a New Generation of Stem Cell Trials in Patients with CLI
Marianne Brodmann
5:36 - 5:44 pm
Optimal Trial Design for Novel Therapies in CLI Patients
Mahmood Razavi
5:44 - 6:00 pm
Discussion
7:30 - 11:00 pm
Venue: Sergeants Mess Chowder Bay
6.45 pm – Transfers: Convention Centre Wharf outside Sofitel Sydney Hotel
Coach transfers back to Sofitel Sydney
7:00 - 7:00 am
Venue – Parkside Ballroom Level 2
8:00 - 9:30 am
Chairs : G. Ansel, R. Varcoe
Panel : S. Bräunlich, Y. Gouëffic, V. Bourke, S. Kum
Supported by : Cook Medical
8:00 - 8:08 am
The BATTLE Trial: A RCT Comparing a Bare Metal Stent versus Paclitaxel Polymer Free Eluting Stent: 2-Year Outcomes
Yann Gouëffic
8:08 - 8:38 am
Live Case from Leipzig (case 19)
8:38 - 8:46 am
Latest Results from the REAL PTX Randomized Trial
Sven Bräunlich
8:46 - 8:54 am
Endovascular Intervention vs. Open Surgery for Lower Limb Ischaemia- Resources Optimization
Yew Toh Wong
8:54 - 9:02 am
Why we need to be scientific in our evaluation of pedal access utilization
Gary Ansel
9:02 - 9:10 am
Stretching and damage of the vessel wall due to SES deployment, a histological and mechanical evaluation
Matthew Pelletier
9:10 - 9:30 am
Discussion
9:30 - 11:00 am
Chairs : R. Varcoe, J. Van den Berg
Panel : R. Tripathi, M. Razavi, S. Bräunlich, A. Ling, R. Tripathi, Y. Gouëffic
9:30 - 9:38 am
Advanced Interventional Techniques to Conquer the Reclacitrant CTO: Has to Achieve 100% Technical Success
Sven Bräunlich
9:38 - 9:58 am
Live Case from Sydney POW (case 21)
9:58 - 10:06 am
Approaches after Failed CTO Crossing
Mahmood Razavi
10:06 - 10:14 am
The Use of Specialty Balloons in the BTK Segment
Jos Van den Berg
10:14 - 10:22 am
Balloon Based versus Stent Based Tibial Revascularisation: The Evidence for Each
Adrian Ling
10:22 - 10:30 am
French Guidelines for the Management of Ambulatory Endovascular Procedures for Lower Extremity Peripheral Artery Disease
Yann Gouëffic
10:30 - 10:38 am
Distal Bypasses Have An Important Role In The Treatment Of CLTI In The Endovascular Era: What Is That Role ?
Ramesh Tripathi
10:38 - 11:00 am
Discussion
11:30 - 11:38 am
Chairs : F. Criado, H. Verhagen
Panel : J. Iliopoulos, G. Benveniste, J. Van den Berg, E. Verhoeven, D. Schneider
11:30 - 11:38 am
Technical Lessons Learned in Over 1400 Fenestrated and Branched EVAR Cases
Eric Verhoeven
11:38 - 11:46 am
Combination Approach with fEVAR and chEVAR for Selected Anatomies
Eric Ducasse
11:46 - 11:52 am
Survival after EVAR in octogenarians is similar to a matched control group without an aortic aneurysm from the general population
Hence Verhagen
11:52 - 12:00 pm
Entirely Percutaneous Approaches to Complex EVAR
Darren Schneider
12:00 - 12:08 pm
Long-Term Follow-up from a Single-Surgeon, Data-Linkage Study in 180 Consecutive Patients with Abdominal Aortic Aneurysm Treated with the Endurant Stent Graft System
Glen Benveniste
12:08 - 12:16 pm
New Vascular Imaging Techniques: What Interventionalists Need to Know
Jos Van den Berg
12:16 - 12:24 pm
Most truly inoperable aneurysm patients should be left alone, without repair – regardless of aneurysm size
Frank Criado
12:24 - 12:32 pm
Outcomes of A Low Profile AAA Graft: InCraft
Kishore Sieunarine
12:32 - 12:40 pm
Evolution in Special Forces Trauma Training and Trauma Care/Surgery Since Afghanistan and Iraq
Jim Iliopoulos
12:40 - 12:48 pm
Management of Vascular Trauma in Military Settings
John Swinnen
12:48 - 1:00 pm
Discussion
2:00 - 5:00 pm
Chairs : R. Varcoe, A. Lennox
Panel : H. Verhagen, R. Milner, E. Verhoeven, S. Thomas T. Nakama, S. Kum
2:00 - 2:07 pm
My Worst Ever Disaster…From Rotterdam
Hence Verhagen
2:07 - 2:14 pm
My Worst Ever Disaster…From Sydney
Ravi Huilgol
2:14 - 2:21 pm
My Worst Ever Disaster…From Tokyo
Tatsuya Nakama
2:21 - 2:28 pm
My Worst Ever Disaster…From Lugano
Jos Van den Berg
2:28 - 2:35 pm
My Worst Ever Disaster…From Nuremberg
Eric Verhoeven
2:35 - 2:42 pm
Percutaneous Transapical Approach For Placing Arch And Other Devices: How Is It Possible
Ross Milner
2:42 - 2:49 pm
A Rare Case of Bilateral Posterior Tibial Artery Aneurysm Presenting as Unilateral Acute Limb Ischemia
Andrew Hattam
2:49 - 2:56 pm
Aortic hygroma following endovascular repair of an abdominal aortic aneurysm
Thomas Cavaye
2:56 - 3:03 pm
Primary Retroperitoneal Pseudocysts: Beware of the Hoax Solid Enhancing Adrenal Mass
Matthew Farag
3:03 - 3:10 pm
Surprising renal recovery in an inflammatory abdominal aortic aneurysm
Paul Ghaly
3:10 - 3:17 pm
Percutaneous Endoluminal Anatomical Bypass for a Ligated External Iliac Artery
Tatsuya Nakama
3:17 - 3:24 pm
Aneurysm sac re-perfusion following thoracoabdominal endovascular aortic aneurysm repair to mitigate spinal cord ischaemia
Joseph Faraj
3:24 - 3:31 pm
SMA Syndrome causing gastric outlet obstruction
Kishan Liyanage
3:31 - 3:38 pm
Wrapping of an ascending aorta aneurysm and Hybrid technique for Acute TBAD in high risk patient
Son Nguyen
3:38 - 3:45 pm
Mycotic iliac artery pseudoaneurysm from disseminated Bacillus Calmette-Guerin mycobacteria
Kam Fai (Kelvin) Ho
3:45 - 3:52 pm
Hybrid revascularization in an old monk with TASC-D AIOD, how I do it?
Jaroen Cheewinmethasiri
3:52 - 3:59 pm
Lower extremity oedema as a sentinel symptom
Ian Barry
3:59 - 4:06 pm
Hybrid operative management of ruptured acute non-A/non-B aortic dissection
Enis Kocak
4:06 - 4:13 pm
A real pickle: Preserving erectile function in ruptured iliac aneurysms
Rebecca Reardon
4:13 - 4:20 pm
Getting flow A case of chronic and acute mesenteric ischaemia
Ina Liang
4:20 - 4:27 pm
A case of challenging BTK and BTA intervention with metatarsal artery puncture and BADFORM technique
Yuta Azumi
4:27 - 4:34 pm
Concurrent radiation induced aortoiliac occlusive disease and May Thurner syndrome; a novel endovascular approach and review of the literature.
Lucy Mauel
4:34 - 4:41 pm
A Novel Method of Concomitant In-situ Fenestration of Left Subclavian Artery in TEVAR-the J.D method
Ji Dong Liu
4:41 - 5:00 pm
Discussion
8:00 - 9:30 am
Chair : J. Van den Berg
Panel : G. Goh, L. Baker, T. Kolbel
8:00 - 8:10 am
An Update on Treatment for Endoleaks
Jos Van den Berg
8:10 - 8:20 am
Anti-Reflux and Balloon Microcatheter Embolization – Game Changers?
Gerard Goh
8:20 - 8:50 am
Live Case from Sydney POW (case 20)
8:50 - 9:00 am
Transcaval Endoleak Embolisation
Tilo Kolbel
9:00 - 9:10 am
Direct Stick Puncture Technique to Manage Endoleaks
Luke Baker
9:10 - 9:20 am
Live Case from Sydney POW (case 20)
9:20 - 9:30 am
Discussion
9:30 - 11:00 am
Chair : M. Malouf
Panel : N. Ibrahim, S. Roberts, I. Mohan, P. Premkumar
9:30 - 9:40 am
Highlights of Venous 2019 Meetings: My Take on Where the Future of Venous Therapies
Mark Malouf
9:40 - 9:50 am
Preliminary Experience of Cyanoacrylate Closure – Single Centre Data
Stefania Roberts
9:50 - 10:00 am
Vena-Plug: Cyanoacrylate Beyond Truncal Ablation
Nabeel Ibrahim
10:00 - 10:10 am
Unanswered Questions on Thermal Ablation of Truncal Venous Incompetence
Irwin Mohan
10:10 - 10:20 am
Unmasking Iliac veins abnormality by ascending venogram in venous ulcers
Prabhu Premkumar
10:20 - 10:30 am
Use of a sub-bandage pressure monitor to improve accuracy of pressure bandage applicatio
Gabrielle McMullin
10:30 - 10:40 am
Radiofrequency ablation of varicose veins: audit of outcomes from the public sector
Michael Smits
10:40 - 10:50 am
A Practical Guide to Sclerotherapy
Stefania Roberts
10:50 - 11:00 am
Discussion
11:30 - 1:00 pm
Chairs : P. Schneider, K. Rosenfeld
Panel : M. Schermerhorn, M. Neale, A. Bullen, R. Huilgol
11:30 - 11:38 am
Current Considerations for Patient Centred Revascularisation Strategies: CAS vs CEA vs BMT
Michael Neale
11:38 - 11:46 am
The Current Status of Carotid Stenting in 2019
Kenneth Rosenfield
11:46 - 11:54 am
New Devices and Techniques in Carotid Stenting
Andrew Bullen
11:54 - 12:02 pm
An Update on the Vascular Quality Initiative (VQI), Transcervical Carotid Revascularization Surveillance Project
Marc Shermerhorn
12:02 - 12:10 pm
The Use of Micromesh Covered Stents in CAS
Ravi Huilgol
12:10 - 12:18 pm
Use of TCAR in recently symptomatic patients: Is it safe?
Peter Schneider
12:18 - 12:26 pm
PARADIGM-Extend prospective academic trial: Accumulating long-term evidence for MicroNet-covered stent safety and stroke prevention efficacy and Initial experience from Perth
Patrice Mwipitayi
12:26 - 12:34 pm
A tortuous internal carotid artery aneurysm
Reuben Chen
12:34 - 12:42 pm
Spontaneous Recanalisation of an Occluded Internal Carotid Artery
Rebecca Reardon
12:42 - 1:00 pm
Discussion
Due to Covid-19, the 2020 Verve Symposium has been postponed to 2021. More information is available here.
We will keep you updated via our website or contact the Symposium Secretariat.